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In 2009, an outbreak of raccoon rabies in Central Park 
in New York City, New York, USA, infected 133 raccoons. 
Five persons and 2 dogs were exposed but did not become 
infected. A trap-vaccinate-release program vaccinated ≈500 
raccoons and contributed to the end of the epizootic.
C
entral Park, described as an oasis in the midst of 
an urban jungle, spans 843 acres. Raccoons thrive 
in Central Park, an ideal habitat with an abundance of 
human refuse as food. Although not actually counted, the 
estimated raccoon population in the park is ≈500. Each 
year, Central Park receives >25 million visitors, offering 
ample opportunity for humans and off-leash dogs to be 
exposed to raccoons.
On August 27, 2009, a sick raccoon collected from 
Central Park in Manhattan tested positive for rabies virus, 
marking the emergence of an enzootic of raccoon rabies 
in Central Park. From December 2009 through December 
2011, rabies test results for 133 raccoons collected in or 
near Central Park were also positive (Figure 1). The New 
York City Department of Health and Mental Hygiene 
(DOHMH) quickly assembled a task force with the 
objective of developing a response plan. The task force 
comprised members of the New York City DOHMH, 
the US Department of Agriculture Wildlife Services, the 
Central Park Conservancy, the New York City Department 
of Parks and Recreation, the New York State Department 
of Health, New York City Animal Care and Control, 
and the New York State Department of Environmental 
Conservation. A trap-vaccinate-release (TVR) plan was 
developed and implemented. 
The Program
The trap-vaccinate-release program goals were to 
reduce transmission of rabies among raccoons and prevent 
human and pet exposure to rabid raccoons. The few 
examples of raccoon rabies epizootics in similar settings 
often used a point infection control approach: oral rabies 
vaccine, depopulation of up to 80% of the raccoons, and 
TVR (1–6).
For the Central Park outbreak, oral rabies vaccine was 
ruled out because of the small but potential risk for vaccinia 
infections of humans (7,8), given the large volume of park 
visitors and poor raccoon seroconversion rates (9%–61%) 
(9–14). Depopulation was also eliminated because it would 
have overwhelmed the animal shelter system with demand 
for humane euthanasia and decapitations and because a 
national animal welfare organization and the public voiced 
opposition. Thus, the task force chose TVR. 
The makeup of Central Park and the surrounding 
Manhattan area creates a ﬁ   shbowl-style habitat; inside 
the park are acres of ideal living habitat, surrounded by a 
mass of concrete, roadways, vehicles, and pedestrians, to 
contain the raccoons. Central Park and 2 small parks in 
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Figure 1.  Location of rabid raccoons in and around Central Park, 
New York City, New York, USA, December 1, 2009–December 1, 
2011. Each dot represents a rabid raccoon.Program to Control Raccoon Rabies, New York, USA
close proximity were targeted for 3 rounds of TVR. The 
public was notiﬁ  ed through press releases, posters, ﬂ  yers, 
electronic messaging, and the New York City 311 telephone 
information service. Community boards, political leaders, 
and human and animal health communities were notiﬁ  ed 
directly. The DOHMH website was kept updated.
The 3 rounds of TVR were conducted: February 
16–April 7, 2010, September 20–November 5, 2010, 
and November 28–December 16, 2011. Trapping efforts 
were focused in Central Park, followed by Morningside 
and Riverside Parks. Humane cage traps baited with 
marshmallows and anise oil as a scent attractant were 
placed in sites that were off limits or of limited access to 
the public and their dogs. Each trap had a rabies warning 
sign with emergency contact information.
Trapped raccoons were visually assessed for evidence 
of injury, illness, or death. Raccoons that were ill or injured 
were humanely euthanized and, along with those found 
dead, were submitted for rabies testing at the DOHMH 
Public Health Laboratory. Healthy raccoons were 
immobilized in the trap by a squeeze comb, given 1 mL of 
rabies vaccine in a thigh muscle, identiﬁ  ed by placement 
of an ear tag, and then released at the capture site. Healthy, 
tagged raccoons that were later recaptured during the same 
round of TVR were released, but those recaptured during a 
subsequent TVR round were revaccinated.
During each round of TVR, 26–73 traps were set per 
night, resulting in 3,822 trap-nights (Table). A total of 
1,129 raccoons were trapped (range 0–34/night), of which 
484 raccoons were vaccinated and 112 were revaccinated. 
Among 232 raccoons, there were 586 instances of recapture 
(median 1, range 1–9).
During round 1, of 460 raccoons trapped, 237 were 
deemed healthy, processed, and released (Table). Of 58 
raccoons deemed unhealthy or found dead, 11 were rabies 
positive; of these, 0/6 were dead, 5/8 were sick, and 6/44 
were injured. During round 2, of 459 raccoons trapped, 148 
were newly vaccinated, tagged, and released, and 68 were 
revaccinated. One injured raccoon was euthanized; rabies test 
result was negative. None were found dead or sick. During 
round 3, of 210 raccoons trapped, 99 were newly vaccinated, 
tagged, and released, and 44 were revaccinated. One sick 
raccoon was euthanized; rabies test result was positive.
Among the vaccinated raccoons, rabies later 
developed in 14.  The time between vaccination and 
recapture was 1–26 days (mean 10 days), suggesting that 
they were probably incubating the virus at the time of 
vaccination.
Exposures (conﬁ   rmed or possible raccoon bites, 
contact with raccoon saliva) were identiﬁ  ed for 5 persons 
and 2 dogs, all during January–June, 2010. Each person 
received rabies postexposure prophylaxis. Each dog was 
currently vaccinated against rabies, received a booster 
dose, and was monitored. Rabies did not develop in these 
persons or dogs.
At the peak of the epizootic, 11 rabid raccoons were 
reported per week. By April, the epizootic started to 
decline (Figure 2), probably attributable to the natural 
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Table. Results of raccoon trap-vaccinate-release program, New York, New York, USA, 2010 
Round  Trap nights  No. trapped  No. vaccinated and released  No. recaptured  No. sick, injured, or dead
1 1,697  460  237  165  58 
2 1,409  459*  148  307  1 
3 716  210  99  114  1 
Total 3,822  1,129  484  586  60 
*Three raccoons were submitted for rabies testing after human exposures. 
Figure 2. Number of rabid raccoons, Manhattan, New 
York, USA, by week, during and after the epizootic 
in Central Park and the corresponding dates of the 3 
rounds of the trap-vaccinate-release program (TVR), depopulation resulting from rapid spread of the virus and 
to the population immunity resulting from TVR. The last 
cases of rabid raccoons were reported on February 2 and 
December 9, 2011. 
Conclusions
TVR seems to have effectively stemmed this epizootic 
of rabies in an established raccoon population. Critical to 
its success was the collaboration among federal, state, and 
local agencies and the private organizations responsible 
for park stewardship and animal control. This example 
suggests that a TVR program tailored to the geography, 
scope, and speciﬁ  cs of an epizootic in an urban area can 
successfully immunize a large population of raccoons and 
limit the potential for human and pet exposure to rabies 
virus.
Ongoing surveillance suggests that raccoon rabies 
has been successfully controlled in Manhattan. Had TVR 
not been implemented, the epizootic would probably have 
reached a state of continuous low-level enzootic activity. 
Given the natural border around Manhattan, it is unknown 
how rabies was initially introduced, but theories include 
illegal release of a raccoon or raccoon entry by bridge, 
tunnel, or even vehicle.
Annual use of TVR is not likely. However, after the 
immunized raccoon population declines and subsequent 
generations of susceptible animals predominate, another 
large epizootic could occur. Given the favorable park 
environment in which raccoon numbers can grow almost 
unchecked, population control should be explored as 
another way to prevent a recurrent epizootic with a similar 
explosive pattern. Public health and wildlife ofﬁ  cials, along 
with academicians, should continue to explore efforts to 
develop safe, effective, and acceptable population control 
measures to help manage the unchecked growth of wildlife 
supported by urban centers.
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